Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Slavin, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 255 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gross, DJ; Weiss, L; Reibstein, I; Hedlund, G; Dahlen, E; Rapoport, MJ; Slavin, S
      The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    3. Slavin, S; Nagler, A; Shapira, M; Panigrahi, S; Samuel, S; Or, A
      Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    4. Slavin, S
      Recreational use of amyl nitrite

      VENEREOLOGY-THE INTERDISCIPLINARY INTERNATIONAL JOURNAL OF SEXUAL HEALTH
    5. Ball, LJ; Lambell, NJ; Ormerod, TC; Slavin, S; Mariani, JA
      Representing design rationale to support innovative design reuse: a minimalist approach

      AUTOMATION IN CONSTRUCTION
    6. Slavin, S; Or, R; Aker, M; Shapira, MY; Panigrahi, S; Symeonidis, A; Cividalli, G; Nagler, A
      Nonmyeloablative stem cell transplantation for the treatment of cancer andlife-threatening nonmalignant disorders: past accomplishments and future goals

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Burt, RK; Barr, W; Oyama, Y; Traynor, A; Slavin, S
      Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    8. Nagler, A; Aker, M; Or, R; Naparstek, E; Varadi, G; Brautbar, C; Slavin, S
      Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

      EXPERIMENTAL HEMATOLOGY
    9. Slavin, S; Ackerstein, A; Morecki, S; Gelfand, Y; Cividalli, G
      Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes

      BONE MARROW TRANSPLANTATION
    10. Morecki, S; Gelfand, Y; Nagler, A; Or, R; Naparstek, E; Varadi, G; Engelhard, D; Akerstein, A; Slavin, S
      Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

      BONE MARROW TRANSPLANTATION
    11. Panigrahi, S; Nagler, A; Or, R; Wolf, DG; Slavin, S; Shapira, MY
      Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation

      BONE MARROW TRANSPLANTATION
    12. Slavin, S; Nagler, A; Panigrahi, S; Varadi, G; Ackerstein, A; Samuel, S; Or, R
      Shifting towards better immunotherapy rather than more intensive chemoradiotherapy using a non-myeloablative approach in patients with leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    13. Morecki, S; Slavin, S
      Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    14. Leshem, B; Vourka-Karussis, U; Slavin, S
      Correlation between enhancement of graft-versus-leukemia effects followingallogeneic bone marrow transplantation by rIL-2 and increased frequency ofcytotoxic T-lymphocyte precursors in murine myeloid leukemia

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    15. Hiller, C; Wittmann, S; Slavin, S; Fickenscher, H
      Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector

      GENE THERAPY
    16. Slavin, S
      New strategies for bone marrow transplantation

      CURRENT OPINION IN IMMUNOLOGY
    17. Levy, J; Amar, A; Brautbar, C; Slavin, S; Kapelushnik, J
      Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment

      ACTA PAEDIATRICA
    18. Carella, AM; Giralt, S; Slavin, S
      Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia

      HAEMATOLOGICA
    19. Morecki, S; Yacovlev, E; Gelfand, Y; Trembovler, V; Shohami, E; Slavin, S
      Induction of antitumor immunity by indomethacin

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    20. Nagler, A; Or, R; Naparstek, E; Varadi, G; Slavin, S
      Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

      EXPERIMENTAL HEMATOLOGY
    21. Slavin, S; Nagler, A; Varadi, G; Or, R
      Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

      EXPERIMENTAL HEMATOLOGY
    22. Nagler, A; Ackerstein, A; Or, R; Naparstek, E; Slavin, S
      Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation

      EXPERIMENTAL HEMATOLOGY
    23. Ilan, Y; Nagler, A; Zeira, E; Adler, R; Slavin, S; Shouval, D
      Maintenance of immune memory to the hepatitis B envelope protein followingadoptive transfer of immunity in bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    24. Carella, AM; Champlin, R; Slavin, S; McSweeney, P; Storb, R
      Mini-allografts: ongoing trials in humans

      BONE MARROW TRANSPLANTATION
    25. Nagler, A; Slavin, S; Varadi, G; Naparstek, E; Samuel, S; Or, R
      Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

      BONE MARROW TRANSPLANTATION
    26. Slavin, S; Or, R; Prighozina, T; Gurevitch, O; Aker, M; Panighari, S; Shapira, M; Nagler, A
      Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man

      BONE MARROW TRANSPLANTATION
    27. Hiller, C; Tamguney, G; Stolte, N; Matz-Rensing, K; Lorenzen, D; Hor, S; Thurau, M; Wittmann, S; Slavin, S; Fickenscher, H
      Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus

      VIROLOGY
    28. Slavin, S
      Cancer immunotherapy with alloreactive lymphocytes

      NEW ENGLAND JOURNAL OF MEDICINE
    29. Weiss, L; Slavin, S; Reich, S; Cohen, P; Shuster, S; Stern, R; Kaganovsky, E; Okon, E; Rubinstein, AM; Naor, D
      Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    30. Champlin, RE; Passweg, JR; Zhang, MJ; Rowlings, PA; Pelz, CJ; Atkinson, KA; Barrett, AJ; Cahn, JY; Drobyski, WR; Gale, RP; Goldman, JM; Gratwohl, A; Gordon-Smith, EC; Henslee-Downey, PJ; Herzig, RH; Klein, JP; Marmont, AM; O'Reilly, RJ; Ringden, O; Slavin, S; Sobocinski, KA; Speck, B; Weiner, RS; Horowitz, MM
      T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities

      BLOOD
    31. Nagler, RM; Reznick, AZ; Slavin, S; Nagler, A
      Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutase

      ARCHIVES OF ORAL BIOLOGY
    32. Slavin, S; Morecki, S; Naparstek, E; Nagler, A; Varadi, G; Ben-Yosef, R; Or, R
      Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation

      ALLOGENEIC IMMUNOTHERAPY FOR MALIGNANT DISEASES
    33. Shalev, M; Ko, A; Gelderman, MP; Fortin, E; Reed, G; Slavin, S; Gery, I
      Multiformic modulation of endotoxin effects by linomide

      CLINICAL IMMUNOLOGY
    34. Slavin, S
      The sociology of social problems: Theoretical perspectives and methods of intervention

      JOURNAL OF SOCIOLOGY
    35. Weiss, L; Reich, S; Slavin, S
      Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    36. Weiss, L; Reich, S; Slavin, S
      Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4(+) and CD8(+) T cells in immunotherapyfor leukemia

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    37. Skootsky, SA; Slavin, S; Wilkes, MS
      Attitudes toward managed care and cost containment among primary care trainees at 3 training sites

      AMERICAN JOURNAL OF MANAGED CARE
    38. Ben Yehuda, A; Wirtheim, E; Abdulhai, A; Or, R; Slavin, S; Babaey, S; Friedman, G
      Activation of the recombination activating gene 1 (RAG-1) transcript in bone marrow of senescent C57BL/6 mice by recombinant interleukin-7

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    39. Gross, DJ; Reibstein, I; Weiss, L; Slavin, S; Stein, I; Neeman, M; Abramovitch, R; Benjamin, LE
      The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice

      CLINICAL CANCER RESEARCH
    40. Aker, M; Varadi, G; Slavin, S; Nagler, A
      Fludarabine-based protocol for human umbilical cord blood transplantation in children with fanconi anemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    41. Mumcuoglu, M; Slavin, S
      Enhancement of hematopoietic reconstitution with recombinant cytokines: Effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow

      JOURNAL OF HEMATOTHERAPY
    42. Varadi, G; Or, R; Kapelushnik, J; Naparstek, E; Nagler, A; Brautbar, C; Amar, A; Kirschbaum, M; Samuel, S; Slavin, S; Siegal, T
      Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma

      LEUKEMIA & LYMPHOMA
    43. Slavin, S; Prighozina, T; Gurevitch, O; Zhu, J; Gross, D; Rabstein, I; Weiss, L
      New approaches for control of anti-self reactivity in type 1 diabetes mellitus and transplantation of pancreatic islets

      JOURNAL OF MOLECULAR MEDICINE-JMM
    44. Naparstek, E; Delukina, M; Or, R; Nagler, A; Kapelushnik, J; Varadi, G; Strauss, N; Cividalli, G; Aker, M; Brautbar, C; Waldmann, H; Hale, G; Slavin, S
      Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies

      EXPERIMENTAL HEMATOLOGY
    45. Vourka-Karussis, U; Ackerstein, A; Pugatsch, T; Slavin, S
      Allogeneic cell-mediated immunotherapy for eradication of minimal residualdisease: Comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models

      EXPERIMENTAL HEMATOLOGY
    46. Globerson, A; Kollet, O; Abel, L; Fajerman, I; Ballin, A; Nagler, A; Slavin, S; Ben Hur, H; Hagay, Z; Sharp, A; Lapidot, T
      Differential effects of CD4(+) and CD8(+) cells on lymphocyte development from human cord blood cells in murine fetal thymus explants

      EXPERIMENTAL HEMATOLOGY
    47. Prigozhina, TB; Gurevitch, O; Slavin, S
      Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice

      EXPERIMENTAL HEMATOLOGY
    48. Nagler, A; Ackerstein, A; Kapelushnik, J; Or, R; Naparstek, E; Slavin, S
      Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

      BONE MARROW TRANSPLANTATION
    49. Rosales, F; Peylan-Ramu, N; Cividalli, G; Varadi, G; Or, R; Naparstek, E; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic bone marrow transplantation for geneticdiseases

      BONE MARROW TRANSPLANTATION
    50. Weiss, L; Slavin, S
      Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin

      BONE MARROW TRANSPLANTATION
    51. Rosales, F; Naparstek, E; Varadi, G; Or, R; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia

      LEUKEMIA RESEARCH
    52. Gurevitch, O; Prigozhina, TB; Pugatsch, T; Slavin, S
      Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment

      TRANSPLANTATION
    53. Hammond, DC; Hidalgo, D; Slavin, S; Spear, S; Tebbetts, J
      Revising the unsatisfactory breast augmentation

      PLASTIC AND RECONSTRUCTIVE SURGERY
    54. Amit, M; Mor, A; Slavin, S; Rapoport, M
      The role of proto-oncogenes in autoimmunity

      DECADE OF AUTOIMMUNITY
    55. Slavin, S
      Autologous and allogenic stem cell transplantation for the treatment of autoimmune diseases as a potential new approach

      DECADE OF AUTOIMMUNITY
    56. OR R; ACKERSTEIN A; NAGLER A; AMAR A; NAPARSTEK E; VARADI G; KAPELUSHNIK J; SAMUEL S; PUGATSCH T; BRAUTBAR C; SLAVIN S
      ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION

      Journal of immunotherapy
    57. AKER M; KAPELUSHNIK J; PUGATSCH T; NAPARSTEK E; BENNERIA S; YEHUDA O; AMAR A; NAGLER A; SLAVIN S; OR R
      DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR

      Journal of pediatric hematology/oncology
    58. WILKES MS; SLAVIN S
      HEART-TRANSPLANTATION SELECTION CRITERIA - ATTITUDES OF ETHNICALLY DIVERSE MEDICAL-STUDENTS

      The Journal of clinical ethics
    59. WILKES MS; USATINE R; SLAVIN S; HOFFMAN JR
      DOCTORING - UNIVERSITY-OF-CALIFORNIA, LOS-ANGELES

      Academic medicine
    60. SLAVIN S; NAGLER A
      IMMUNOTHERAPY IN CONJUNCTION WITH AUTOLOGOUS AND ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION IN LYMPHOMA

      Annals of oncology
    61. NAPARSTEK E; NAGLER A; OR R; VARADI G; BENYOSEF R; ACKERSTEIN A; SLAVIN S
      POST TRANSPLANT IMMUNOTHERAPY FOR PREVENTION OF RELAPSE AFTER AUTOLOGOUS BMT FOR ACUTE-LEUKEMIA

      Experimental hematology
    62. SLAVIN S; NAGLER A; NAPARSTEK E; OR R; VARADI G; BENYOSEF R; HUSSIEN A; AKER M; CIVIDALLI G
      LEUKEMIA IMMUNOTHERAPY IN CONJUNCTION WITH NON MYELOABLATIVE ALLOGENEIC STEM-CELL TRANSPLANTATION

      Experimental hematology
    63. BISHARA A; AKER M; AMAR A; BRAUTBAR C; SCHLESINGER M; RABINOWITZ R; SLAVIN S; BANIYASH M
      ENHANCED LYMPHOID-CELL RECOVERY AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH THE PRESENCE OF COSTIMULATORY ANTIBODIES IN SERUM

      Experimental hematology
    64. KAPELUSHNIK J; AKER M; PUGATSCH T; SAMUEL S; SLAVIN S
      BONE-MARROW TRANSPLANTATION FROM A CADAVERIC DONOR

      Bone marrow transplantation
    65. SLAVIN S; NAGLER A; NAPARSTEK E; ACKERSTEIN A; KAPELUSHNIK Y; VARADI G; ALLAYAN H; KIRSCHBAUM M; BENYOSEF R; SAMUEL S
      ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOLLOWING NON-MYELOABLATIVE CONDITIONING FOR THE TREATMENT OF MALIGNANT AND NONMALIGNANT DISEASES

      Bone marrow transplantation
    66. NAGLER A; NAPARSTEK E; OR R; VARADI G; SLAVIN S
      THIOTEPA, BUSULFAN, CYCLOPHOSPHAMIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE-LEUKEMIA

      Bone marrow transplantation
    67. ENGELHARD D; OR R; STRAUSS N; ELISHOOV H; NAPARSTEK E; AKER M; CIVIDALLI G; NAGLER A; KAPELUSHNIK Y; SIMHON A; SHAPIRO M; MAAYAN S; RAHAV G; MOSES AE; SLAVIN S
      RISK-FACTORS FOR NOSOCOMIAL SEPTICEMIA FOLLOWING BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    68. ACKERSTEIN A; NAGLER A; NAPARSTEK E; KAPELUSHNIK J; VARADI G; SLAVIN S; OR R
      LONG-TERM IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA)FOR MULTIPLE-MYELOMA PATIENTS FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)

      Bone marrow transplantation
    69. NAGLER A; KAPELUSHNIK I; AKER M; OR R; SLAVIN S
      ALLOGENEIC BONE-MARROW AND CORD-BLOOD TRANSPLANTATIONS FOR FANCONIS-ANEMIA (FA) USING A NOVEL CONDITIONING REGIMEN WITH NO IRRADIATION

      Bone marrow transplantation
    70. SLAVIN S
      THE RIGHT TO PRIVACY - GAYS, LESBIANS, AND THE CONSTITUTION - SAMAR,VJ

      Women & politics
    71. SLAVIN S
      LESBIAN (OUT)LAW - SURVIVAL UNDER THE RULE OF LAW - ROBSON,R

      Women & politics
    72. SLAVIN S
      WOMEN IN AMERICAN LAW - THE STRUGGLE TOWARD EQUALITY FROM THE NEW-DEAL TO THE PRESENT - BAER,JA

      Women & politics
    73. MORECKI S; NAGLER A; ZAKAYRONES Z; SCHLESINGER M; LUBINASALOMON A; PUGATSCH T; MOSHEL Y; SLAVIN S
      TUMORIGENICITY AND IMMUNOGENICITY IN A MURINE MODEL OF B-CELL LEUKEMIA LYMPHOMA (BCL1)/

      Leukemia research
    74. NAGLER A; FINLANDER R; OR R; NAPARSTEK E; VARADI G; SLAVIN S
      THE ROLE OF THIOTEPA IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA

      Leukemia research
    75. Slavin, S; Gurevitch, O; Zhu, J; Prighozina, T
      Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for inductionof transplantation tolerance to organ allografts and xenografts

      TRANSPLANTATION PROCEEDINGS
    76. NAGLER A; CONDIOTTI R; NABET C; NAPARSTEK E; OR R; SAMUEL S; SLAVIN S
      SELECTIVE CD4(-CELL DEPLETION DOES NOT PREVENT GRAFT-VERSUS-HOST DISEASE() T)

      Transplantation
    77. BENYOSEF R; POLACHEK I; SLAVIN S; TOCHNER Z; ENGELHARD D
      RADIATION-THERAPY AND INVASIVE FUNGAL INFECTION IN PATIENTS UNDERGOING STEM-CELL TRANSPLANTATION

      Radiology
    78. MORECKI S; YACOVLEV L; SLAVIN S
      EFFECT OF INDOMETHACIN ON TUMORIGENICITY AND IMMUNITY INDUCTION IN A MURINE MODEL OF MAMMARY-CARCINOMA

      International journal of cancer
    79. GROSS DJ; WEISS L; REIBSTEIN I; VANDENBRAND J; OKAMOTO H; CLARK A; SLAVIN S
      AMELIORATION OF DIABETES IN NONOBESE DIABETIC MICE WITH ADVANCED DISEASE BY LINOMIDE-INDUCED IMMUNOREGULATION COMBINED WITH REG PROTEIN TREATMENT

      Endocrinology
    80. MORECKI S; YACOVLEV E; DIAB A; SLAVIN S
      ALLOGENEIC CELL THERAPY FOR A MURINE MAMMARY-CARCINOMA

      Cancer research
    81. SLAVIN S; NAGLER A; NAPARSTEK E; KAPELUSHNIK Y; AKER M; CIVIDALLI G; VARADI G; KIRSCHBAUM M; ACKERSTEIN A; SAMUEL S; AMAR A; BRAUTBAR C; BENTAL O; ELDOR A; OR R
      NONMYELOABLATIVE STEM-CELL TRANSPLANTATION AND CELL THERAPY AS AN ALTERNATIVE TO CONVENTIONAL BONE-MARROW TRANSPLANTATION WITH LETHAL CYTOREDUCTION FOR THE TREATMENT OF MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

      Blood
    82. GILON D; SCHECHTER D; REIN AJJT; GIMMON Z; OR R; ROZENMAN Y; SLAVIN S; GOTSMAN MS; NAGLER A
      RIGHT ATRIAL THROMBI ARE RELATED TO INDWELLING CENTRAL VENOUS CATHETER POSITION - INSIGHTS INTO TIME-COURSE AND POSSIBLE MECHANISM OF FORMATION

      The American heart journal
    83. NAGLER A; ACKERSTEIN A; BENSHAHAR M; OR R; NAPARSTEK E; BENYOSEF R; SLAVIN S
      CONTINUOUS INTERLEUKIN-2 INFUSION COMBINED WITH CYCLOPHOSPHAMIDE-BASED COMBINATION CHEMOTHERAPY IN THE TREATMENT OF HEMATO-ONCOLOGICAL MALIGNANCIES - RESULTS OF A PHASE I-II STUDY

      Acta haematologica
    84. MORECKI S; LUBINASALOMON A; SLAVIN S; NAGLER A
      CYTOKINE GENE TRANSDUCTION INTO NON-IMMUNOGENEIC MURINE TUMOR-CELLS

      Cytokines cellular & molecular therapy
    85. OR R; ACKERSTEIN A; NAGLER A; KAPELUSHNIK J; NAPARSTEK E; SAMUEL S; AMAR A; BRUATBAR C; SLAVIN S
      ALLOGENEIC CELL-MEDIATED IMMUNOTHERAPY FOR BREAST-CANCER AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - A CLINICAL PILOT-STUDY

      Cytokines cellular & molecular therapy
    86. CHEBATH J; FISCHER D; KUMAR A; OH JW; KOLETT O; LAPIDOT T; FISCHER M; ROSEJOHN S; NAGLER A; SLAVIN S; REVEL M
      INTERLEUKIN-6 RECEPTOR-INTERLEUKIN-6 FUSION PROTEINS WITH ENHANCED INTERLEUKIN-6 TYPE PLEIOTROPIC ACTIVITIES

      European cytokine network
    87. SLAVIN S; NAGLER A
      CYTOKINE-MEDIATED IMMUNOTHERAPY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOMA AND EVIDENCE OF INTERLEUKIN-2-INDUCED IMMUNOMODULATION IN ALLOGENEIC TRANSPLANTS

      The cancer journal from Scientific American
    88. MORECKI S; GELFAND Y; LEVI S; NAGLER A; CONDIOTTI R; NABET C; ACKERSTEIN A; SLAVIN S
      ACTIVATED LONG-TERM PERIPHERAL-BLOOD CULTURES AS PREPARATION FOR ADOPTIVE ALLOREACTIVE CELL THERAPY IN CANCER-PATIENTS

      Journal of hematotherapy
    89. MORECKI S; NABET C; FALK P; FRIDKISHARELI M; PECHT I; MOND JJ; SLAVIN S
      THE EFFECT OF LINOMIDE, AN IMMUNOREGULATOR IN EXPERIMENTAL AUTOIMMUNE-DISEASES, ON HUMORAL ANTIBODY-RESPONSES IN MICE

      Autoimmunity
    90. PUGATSCH T; OR R; SLAVIN S; KAPELUSHNIK J
      AMELOGENIN AS MARKER FOR BONE-MARROW ENGRAFTMENT - A SHORT-TERM STUDY

      Journal of tumor marker oncology
    91. SLAVIN S; NAGLER A; NAPARSTEK E; KAPELUSHNIK J; VARADI G; KIRSCHBAUM M; HUSSIEN A; ACKERSTEIN A; OR R
      NON MYELOABLATIVE CONDITIONING IN PREPARATION FOR ALLOGENEIC STEM-CELL TRANSPLANTATION - THE FUTURE TREATMENT OF CHOICE OF HEMATOLOGIC MALIGNANCIES AND GENETIC-DISEASES

      Experimental hematology
    92. ABDULHAI A; BENYEHUDA A; GALSKY H; WEISS L; SLAVIN S; OR R
      IL-7 INDUCED IMMUNE RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION AND ENHANCED GRAFT VS LEUKEMIA EFFECT

      Experimental hematology
    93. BENYOSEF R; OR R; NAPARSTEK E; KAPELUSHNIK J; SAMUELS S; SLAVIN S; NAGLER A
      SHOULD SOYBEAN AGGLUTININ PURGING BE PERFORMED IN BREAST-CANCER PATIENTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF 48 PATIENTS

      American journal of clinical oncology
    94. KAPELUSHNIK J; OR R; SLAVIN S; NAGLER A
      A FLUDARABINE-BASED PROTOCOL FOR BONE-MARROW TRANSPLANTATION IN FANCONI ANEMIA

      Bone marrow transplantation
    95. ABDULHAI A; BENYEHUDA A; WEISS L; FRIEDMAN G; ZAKAYRONES Z; SLAVIN S; OR R
      INTERLEUKIN-7-ENHANCED CYTOTOXIC T-LYMPHOCYTE ACTIVITY AFTER VIRAL-INFECTION IN MARROW TRANSPLANTED MICE

      Bone marrow transplantation
    96. PRIGOZHINA TB; GUREVITCH O; ZHU J; SLAVIN S
      INDUCTION OF MIXED HEMATOPOIETIC CHIMERISM AND SPECIFIC TRANSPLANTATION TOLERANCE TO ALLOGENEIC AND XENOGENEIC GRAFTS BY SELECTIVE ELIMINATION OF DONOR-REACTIVE HOST-CELLS FOLLOWING NONMYELOABLATIVE CONDITIONING

      Transplantation proceedings
    97. SLAVIN S; WEISS L; PRIGHOZINA T; GUREVITCH O; ZHU J; RABSTEIN I; GROSS D
      NEW APPROACHES FOR CONTROL OF ANTI-SELF-REACTIVITY IN TYPE-1 DIABETESAND TRANSPLANTATION OF PANCREATIC-ISLETS

      Transplantation proceedings
    98. PRIGOZHINA TB; GUREVITCH O; ZHU J; SLAVIN S
      PERMANENT AND SPECIFIC TRANSPLANTATION TOLERANCE INDUCED BY A NONMYELOABLATIVE TREATMENT TO A WIDE VARIETY OF ALLOGENEIC TISSUES .1. INDUCTION OF TOLERANCE BY A SHORT-COURSE OF TOTAL LYMPHOID IRRADIATION AND SELECTIVE ELIMINATION OF THE DONOR-SPECIFIC HOST LYMPHOCYTES

      Transplantation
    99. SHAPIRANAHOR O; MARCUS H; SEGALL H; LUBIN I; SLAVIN S; PANET A; REISNER Y
      HUMAN T-CELLS RECOVERED FROM HUMAN BALB RADIATION CHIMERAS ARE HYPERSENSITIVE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION/

      Journal of virology
    100. RAPOPORT M; MOR A; BISTRITZER T; RAMOT Y; LEVI O; SLAVIN S; WYSENBEEK A
      PROTOONCOGENES AND AUTOIMMUNITY

      Israel journal of medical sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 06:31:21